Coordinated regulation of miR-155 and miR-146a genes during induction of endotoxin tolerance in macrophages

Journal of Immunology

Volumn 195, Issue 12, 2015, Pages 5750-5761

  Doxaki, Christina ^a   Kampranis, Sotirios C ^a   Eliopoulos, Aristides G ^a,b   Spilianakis, Charalampos ^b,c   Tsatsanis, Christos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; HISTONE H3; LYSINE; MICRORNA 146A; MICRORNA 155; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; ENDOTOXIN; MICRORNA; MIRN146 MICRORNA, MOUSE; MIRN155 MICRORNA, MOUSE; ONCOPROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTOXIN TOLERANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE LOCUS; GENE SILENCING; GENETIC ASSOCIATION; IMMUNOLOGICAL TOLERANCE; MACROPHAGE; MACROPHAGE ACTIVATION; MONOALLELLE INTERCHROMOSOMAL ASSOCIATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ISOLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; ALLELE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENETIC REPRESSION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; METABOLISM; METHYLATION; PERITONEUM MACROPHAGE; RNA INTERFERENCE; SEPTIC SHOCK;

ALLELES; ANIMALS; CELL LINE; CELLS, CULTURED; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENDOTOXINS; EPIGENETIC REPRESSION; IMMUNE TOLERANCE; IMMUNITY, INNATE; MACROPHAGES, PERITONEAL; METHYLATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; ONCOGENE PROTEIN V-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SHOCK, SEPTIC;

EID: 84958267870     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500615     Document Type: Article

References (72)

1. Androulidaki, A., D. Iliopoulos, A. Arranz, C. Doxaki, S. Schworer, V. Zacharioudaki, A. N. Margioris, P. N. Tsichlis, and C. Tsatsanis. 2009. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
2. El Gazzar, M., and C. E. McCall. 2010. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J. Biol. Chem. 285: 20940-20951.
3. Liu, Y., Q. Chen, Y. Song, L. Lai, J. Wang, H. Yu, X. Cao, and Q. Wang. 2011. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett. 585: 1963-1968.
4. Quinn, E. M., J. Wang, and H. P. Redmond. 2012. The emerging role of microRNA in regulation of endotoxin tolerance. J. Leukoc. Biol. 91: 721-727.
5. Chassin, C., M. Kocur, J. Pott, C. U. Duerr, D. Gütle, M. Lotz, and M. W. Hornef. 2010. miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host Microbe 8: 358-368.
6. Banerjee, S., J. Meng, S. Das, A. Krishnan, J. Haworth, R. Charboneau, Y. Zeng, S. Ramakrishnan, and S. Roy. 2013. Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a. Sci. Rep. 3: 1977.
7. Alexander, M., R. Hu, M. C. Runtsch, D. A. Kagele, T. L. Mosbruger, T. Tolmachova, M. C. Seabra, J. L. Round, D. M. Ward, and R. M. O'Connell. 2015. Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat. Commun. 6: 7321.
8. Jurado-Camino, T., R. Córdoba, L. Esteban-Burgos, E. Hernández-Jiménez, V. Toledano, J. A. Hernandez-Rivas, E. Ruiz-Sainz, T. Cobo, M. Siliceo, R. Perez de Diego, et al. 2015. Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance. J. Immunol. 194: 719-727.
9. Schulte, L. N., A. J. Westermann, and J. Vogel. 2013. Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. Nucleic Acids Res. 41: 542-553.
10. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
11. Kagiya, T., and S. Nakamura. 2013. Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation. J. Periodontal Res. 48: 373-385.
12. Kutty, R. K., C. N. Nagineni, W. Samuel, C. Vijayasarathy, C. Jaworski, T. Duncan, J. E. Cameron, E. K. Flemington, J. J. Hooks, and T. M. Redmond. 2013. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1b, tumor necrosis factor-a, and interferon-g. Mol. Vis. 19: 737-750.
13. Nahid, M. A., K. M. Pauley, M. Satoh, and E. K. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J. Biol. Chem. 284: 34590-34599.
14. O'Connell, R. M., K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104: 1604-1609.
15. Perry, M. M., A. E. Williams, E. Tsitsiou, H. M. Larner-Svensson, and M. A. Lindsay. 2009. Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett. 583: 3349-3355.
16. Kutty, R. K., C. N. Nagineni, W. Samuel, C. Vijayasarathy, J. J. Hooks, and T. M. Redmond. 2010. Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem. Biophys. Res. Commun. 402: 390-395.
17. Pauley, K. M., M. Satoh, A. L. Chan, M. R. Bubb, W. H. Reeves, and E. K. Chan. 2008. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 10: R101.
18. Stanczyk, J., D. M. Pedrioli, F. Brentano, O. Sanchez-Pernaute, C. Kolling, R. E. Gay, M. Detmar, S. Gay, and D. Kyburz. 2008. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58: 1001-1009.
19. Wang, G., L. S. Tam, B. C. Kwan, E. K. Li, K. M. Chow, C. C. Luk, P. K. Li, and C. C. Szeto. 2012. Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin. Rheumatol. 31: 435-440.
20. Wang, G., B. C. Kwan, F. M. Lai, K. M. Chow, P. K. Li, and C. C. Szeto. 2011. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis. Markers 30: 171-179.
21. Kin, K., S. Miyagawa, S. Fukushima, Y. Shirakawa, K. Torikai, K. Shimamura, T. Daimon, Y. Kawahara, T. Kuratani, and Y. Sawa. 2012. Tissue-and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc. 1: e000745.
22. Tsatsanis, C., J. Bobjer, H. Rastkhani, E. Dermitzaki, M. Katrinaki, A. N. Margioris, Y. L. Giwercman, and A. Giwercman. 2015. Serum miR-155 as a potential biomarker of male fertility. Hum. Reprod. 30: 853-860.
23. Xie, Y. F., R. Shu, S. Y. Jiang, D. L. Liu, and X. L. Zhang. 2011. Comparison of microRNA profiles of human periodontal diseased and healthy gingival tissues. Int. J. Oral Sci. 3: 125-134.
24. Corral-Fernández, N. E., M. Salgado-Bustamante, M. E. Martínez-Leija, N. Cortez-Espinosa, M. H. Garćia-Hernández, E. Reynaga-Hernández, R. Quezada-Calvillo, and D. P. Portales-Pérez. 2013. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 121: 347-353.
25. Doxakis, E. 2013. Principles of miRNA-target regulation in metazoan models. Int. J. Mol. Sci. 14: 16280-16302.
26. Etzrodt, M., V. Cortez-Retamozo, A. Newton, J. Zhao, A. Ng, M. Wildgruber, P. Romero, T. Wurdinger, R. Xavier, F. Geissmann, et al. 2012. Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Reports 1: 317-324.
27. Kluiver, J., A. van den Berg, D. de Jong, T. Blokzijl, G. Harms, E. Bouwman, S. Jacobs, S. Poppema, and B. J. Kroesen. 2007. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 26: 3769-3776.
28. Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403: 41-45.
29. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293: 1074-1080.
30. Santos-Rosa, H., R. Schneider, A. J. Bannister, J. Sherriff, B. E. Bernstein, N. C. Emre, S. L. Schreiber, J. Mellor, and T. Kouzarides. 2002. Active genes are tri-methylated at K4 of histone H3. Nature 419: 407-411.
31. Bernstein, B. E., M. Kamal, K. Lindblad-Toh, S. Bekiranov, D. K. Bailey, D. J. Huebert, S. McMahon, E. K. Karlsson, E. J. Kulbokas, III, T. R. Gingeras, et al. 2005. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181.
32. Schneider, R., A. J. Bannister, F. A. Myers, A. W. Thorne, C. Crane-Robinson, and T. Kouzarides. 2004. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6: 73-77.
33. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
34. Foster, S. L., and R. Medzhitov. 2009. Gene-specific control of the TLR-induced inflammatory response. Clin. Immunol. 130: 7-15.
35. Lyn-Kew, K., E. Rich, X. Zeng, H. Wen, S. L. Kunkel, M. W. Newstead, U. Bhan, and T. J. Standiford. 2010. IRAK-M regulates chromatin remodeling in lung macrophages during experimental sepsis. PLoS One 5: e11145.
36. Jing, J., I. V. Yang, L. Hui, J. A. Patel, C. M. Evans, R. Prikeris, L. Kobzik, B. P. O'Connor, and D. A. Schwartz. 2013. Role of macrophage receptor with collagenous structure in innate immune tolerance. J. Immunol. 190: 6360-6367.
37. Belmont, A. S. 2014. Large-scale chromatin organization: the good, the surprising, and the still perplexing. Curr. Opin. Cell Biol. 26: 69-78.
38. Hübner, M. R., M. A. Eckersley-Maslin, and D. L. Spector. 2013. Chromatin organization and transcriptional regulation. Curr. Opin. Genet. Dev. 23: 89-95.
39. Merkenschlager, M., and D. T. Odom. 2013. CTCF and cohesin: linking gene regulatory elements with their targets. Cell 152: 1285-1297.
40. Hübner, M. R., and D. L. Spector. 2010. Chromatin dynamics. Annu. Rev. Biophys. 39: 471-489.
41. Dekker, J., M. A. Marti-Renom, and L. A. Mirny. 2013. Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data. Nat. Rev. Genet. 14: 390-403.
42. Deligianni, C., and C. G. Spilianakis. 2012. Long-range genomic interactions epi-genetically regulate the expression of a cytokine receptor. EMBO Rep. 13: 819-826.
43. Spilianakis, C. G., and R. A. Flavell. 2006. Molecular biology. Managing associations between different chromosomes. Science 312: 207-208.
44. Spilianakis, C. G., M. D. Lalioti, T. Town, G. R. Lee, and R. A. Flavell. 2005. Inter-chromosomal associations between alternatively expressed loci. Nature 435: 637-645.
45. Mao, C., E. G. Tili, M. Dose, M. C. Haks, S. E. Bear, I. Maroulakou, K. Horie, G. A. Gaitanaris, V. Fidanza, T. Ludwig, et al. 2007. Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J. Immunol. 178: 5443-5453.
46. Maroulakou, I. G., W. Oemler, S. P. Naber, and P. N. Tsichlis. 2007. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 67: 167-177.
47. Arranz, A., A. Androulidaki, V. Zacharioudaki, C. Martinez, A. N. Margioris, R. P. Gomariz, and C. Tsatsanis. 2008. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol. Immunol. 45: 2970-2980.
48. Vergadi, E., K. Vaporidi, E. E. Theodorakis, C. Doxaki, E. Lagoudaki, E. Ieronymaki, V. I. Alexaki, M. Helms, E. Kondili, B. Soennichsen, et al. 2014. Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J. Immunol. 192: 394-406.
49. Nahid, M. A., M. Satoh, and E. K. Chan. 2011. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J. Immunol. 186: 1723-1734.
50. Chen, D., L. Y. Fu, Z. Zhang, G. Li, H. Zhang, L. Jiang, A. P. Harrison, H. P. Shanahan, C. Klukas, H. Y. Zhang, et al. 2014. Dissecting the chromatin interactome of microRNA genes. Nucleic Acids Res. 42: 3028-3043.
51. Yin, Q., X. Wang, J. McBride, C. Fewell, and E. Flemington. 2008. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J. Biol. Chem. 283: 2654-2662.
52. Chen, Y., F. Siegel, S. Kipschull, B. Haas, H. Fröhlich, G. Meister, and A. Pfeifer. 2013. miR-155 regulates differentiation of brown and beige adipo-cytes via a bistable circuit. Nat. Commun. 4: 1769.
53. Sachdeva, M., Q. Liu, J. Cao, Z. Lu, and Y. Y. Mo. 2012. Negative regulation of miR-145 by C/EBP-b through the Akt pathway in cancer cells. Nucleic Acids Res. 40: 6683-6692.
54. Augui, S., E. P. Nora, and E. Heard. 2011. Regulation of X-chromosome inac-tivation by the X-inactivation centre. Nat. Rev. Genet. 12: 429-442.
55. Chess, A. 2012. Mechanisms and consequences of widespread random mono-allelic expression. Nat. Rev. Genet. 13: 421-428.
56. Rodriguez, I. 2013. Singular expression of olfactory receptor genes. Cell 155: 274-277.
57. Yang, P. K., and M. I. Kuroda. 2007. Noncoding RNAs and intranuclear positioning in monoallelic gene expression. Cell 128: 777-786.
58. Medzhitov, R., and T. Horng. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9: 692-703.
59. Ceppi, M., P. M. Pereira, I. Dunand-Sauthier, E. Barras, W. Reith, M. A. Santos, and P. Pierre. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 106: 2735-2740.
60. Lachner, M., D. O'Carroll, S. Rea, K. Mechtler, and T. Jenuwein. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120.
61. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30: 475-487.
62. Porta, C., M. Rimoldi, G. Raes, L. Brys, P. Ghezzi, D. Di Liberto, F. Dieli, S. Ghisletti, G. Natoli, P. De Baetselier, et al. 2009. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. USA 106: 14978-14983.
63. O'Hara, S. P., P. L. Splinter, G. B. Gajdos, C. E. Trussoni, M. E. Fernandez-Zapico, X. M. Chen, and N. F. LaRusso. 2010. NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J. Biol. Chem. 285: 216-225.
64. Wang, F., M. Demura, Y. Cheng, A. Zhu, S. Karashima, T. Yoneda, Y. Demura, Y. Maeda, M. Namiki, K. Ono, et al. 2014. Dynamic CCAAT/enhancer binding protein-associated changes of DNA methylation in the angiotensinogen gene. Hypertension 63: 281-288.
65. Pham, T. H., C. Benner, M. Lichtinger, L. Schwarzfischer, Y. Hu, R. Andreesen, W. Chen, and M. Rehli. 2012. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 119: e161-e171.
66. Kowenz-Leutz, E., O. Pless, G. Dittmar, M. Knoblich, and A. Leutz. 2010. Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J. 29: 1105-1115.
67. Kaikkonen, M. U., N. J. Spann, S. Heinz, C. E. Romanoski, K. A. Allison, J. D. Stender, H. B. Chun, D. F. Tough, R. K. Prinjha, C. Benner, and C. K. Glass. 2013. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 51: 310-325.
68. Romanoski, C. E., V. M. Link, S. Heinz, and C. K. Glass. 2015. Exploiting genomics and natural genetic variation to decode macrophage enhancers. Trends Immunol. 36: 507-518.
69. Piwien-Pilipuk, G., D. Van Mater, S. E. Ross, O. A. MacDougald, and J. Schwartz. 2001. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3. J. Biol. Chem. 276: 19664-19671.
70. Guo, S., S. B. Cichy, X. He, Q. Yang, M. Ragland, A. K. Ghosh, P. F. Johnson, and T. G. Unterman. 2001. Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta. J. Biol. Chem. 276: 8516-8523.
71. Williams, A., C. G. Spilianakis, and R. A. Flavell. 2010. Interchromosomal association and gene regulation in trans. Trends Genet. 26: 188-197.
72. Papantonis, A., T. Kohro, S. Baboo, J. D. Larkin, B. Deng, P. Short, S. Tsutsumi, S. Taylor, Y. Kanki, M. Kobayashi, et al. 2012. TNFa signals through specialized factories where responsive coding and miRNA genes are transcribed. EMBO J. 31: 4404-4414.